Vor Bio Alternatives & Competitors
12 companies similar to Vor Bio — Vor Bio's vision is to cure blood cancers through cell and genome engineering.
Companies similar to Vor Bio
Adicet Bio, Inc
A biotechnology company discovering and developing first-in-class allogeneic gamma delta C...
Redwood City, United Stat...
Cabaletta Bio
Engineered T cell therapies designed for the treatment of patients with autoimmune disease...
Philadelphia, United Stat...
Orca Bio
Transforming allogeneic cell therapy for patients with cancer and autoimmune diseases.
Menlo Park, United States
MimiVax, Inc.
Disrupting Cancer with Immunotherapy
Buffalo, United States
Track all Vor Bio competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Tango Therapeutics
Targeting tumor suppressor loss to unmask vulnerabilities for the next generation of preci...
Boston, United States
Genenta Science (Nasdaq: GNTA)
Genenta is a clinical stage immuno-oncology company
Milan, Italy
Cavion
Empowering therapies for cancer and neurologic diseases through pioneering ion channel inh...
2seventy bio
It’s about time we think smarter and faster than cancer.
Cambridge, United States
Trillium Therapeutics Inc.
Clinical stage immuno-oncology company developing innovative therapies for the treatment o...
Cambridge, United States
Prescient Therapeutics
A clinical stage oncology company developing personalised medicine approaches to cancer; c...
Australia
온코인사이트---OncoInsight-Co.,-Ltd.-logo.jpg "(주)온코인사이트 / OncoInsight Co., Ltd."){kind=logo}
Xilio Therapeutics, Inc.
Focused on harnessing the immune system to achieve deep and durable clinical responses to...
Waltham, United States
About Vor Bio
Vor Bio is a biotechnology startup founded in 2016 with a vision to cure blood cancers through cell and genome engineering. The company's slogan, "Vor Bio's vision is to cure blood cancers through cell and genome engineering," encapsulates its ambitious goal. Vor Bio is a clinical-stage company based in the United Stat...
Biopharma, Genome Engineering, Cell Therapy, Cancer Treatment, Immuno-oncology, Clinical-stage Company, Hematopoietic Stem Cells, Targeted Therapies, Selective Targeting, Therapy Development, Immunotherapies, Bi-specific Antibodies, CAR-T Therapy, Toxicity Management, Cancer Research
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Vor Bio and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Vor Bio on 9 Jun 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
